Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 22 (RPL12P22)

Target
RPL12P22
Molecular classification
Other (classified as a pseudogene, not a functional protein-coding gene)
01

Overview

Ribosomal protein L12 pseudogene 22 (RPL12P22) is a **pseudogene** found in the human genome. It is named due to its sequence similarity to the functional ribosomal protein L12 gene (RPL12), which encodes a protein component of the 60S ribosomal subunit involved in catalyzing protein synthesis. However, as a pseudogene, RPL12P22 does not produce a functional protein and is not considered a therapeutic target or involved in known biological functions or disease associations. Pseudogenes like RPL12P22 are typically noncoding remnants of once-functional genes that have lost their protein-coding potential due to mutations and other genomic changes[1][2][4][8]. RPL12 is a functional gene coding for a ribosomal protein involved in protein synthesis, but RPL12P22 is only a *genomic relic* and not actively translated or functionally relevant as a therapeutic target[3][5]. No information is available regarding drug interactions, disease links, or biomarker relevance for RPL12P22, because pseudogenes do not produce functional gene products[1][2][4][8].

Other names
RPL12_4_640RPL12P22

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 22 (RPL12P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 22 (RPL12P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call